Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1954 2
1955 1
1956 2
1957 2
1958 2
1959 2
1964 3
1965 1
1966 14
1967 14
1968 17
1969 24
1970 25
1971 18
1972 21
1973 23
1974 18
1975 21
1976 10
1977 13
1978 9
1979 15
1980 19
1981 18
1982 18
1983 24
1984 32
1985 35
1986 25
1987 31
1988 24
1989 30
1990 25
1991 31
1992 40
1993 39
1994 42
1995 51
1996 54
1997 80
1998 70
1999 35
2000 78
2001 58
2002 62
2003 60
2004 76
2005 72
2006 85
2007 83
2008 90
2009 91
2010 91
2011 112
2012 96
2013 99
2014 98
2015 117
2016 91
2017 97
2018 127
2019 121
2020 118
2021 125
2022 126
2023 116
2024 38

Text availability

Article attribute

Article type

Publication date

Search Results

3,010 results

Results by year

Filters applied: . Clear all
Page 1
Management of atrial flutter and atrial fibrillation with rapid ventricular response in patients with acute decompensated heart failure: A systematic review.
Niforatos JD, Ehmann MR, Balhara KS, Hinson JS, Ramcharran L, Lobner K, Weygandt PL. Niforatos JD, et al. Acad Emerg Med. 2023 Feb;30(2):124-132. doi: 10.1111/acem.14618. Epub 2022 Dec 5. Acad Emerg Med. 2023. PMID: 36326565 Free article. Review.
OBJECTIVE: The objective was to evaluate the comparative effectiveness and safety of pharmacological and nonpharmacological management options for atrial fibrillation/atrial flutter with rapid ventricular response (AFRVR) in patients with acute decompensated heart f …
OBJECTIVE: The objective was to evaluate the comparative effectiveness and safety of pharmacological and nonpharmacological management optio …
Effect of Renal Denervation and Catheter Ablation vs Catheter Ablation Alone on Atrial Fibrillation Recurrence Among Patients With Paroxysmal Atrial Fibrillation and Hypertension: The ERADICATE-AF Randomized Clinical Trial.
Steinberg JS, Shabanov V, Ponomarev D, Losik D, Ivanickiy E, Kropotkin E, Polyakov K, Ptaszynski P, Keweloh B, Yao CJ, Pokushalov EA, Romanov AB. Steinberg JS, et al. JAMA. 2020 Jan 21;323(3):248-255. doi: 10.1001/jama.2019.21187. JAMA. 2020. PMID: 31961420 Free PMC article. Clinical Trial.
DESIGN, SETTING, AND PARTICIPANTS: The Evaluate Renal Denervation in Addition to Catheter Ablation to Eliminate Atrial Fibrillation (ERADICATE-AF) trial was an investigator-initiated, multicenter, single-blind, randomized clinical trial conducted at 5 …
DESIGN, SETTING, AND PARTICIPANTS: The Evaluate Renal Denervation in Addition to Catheter Ablation to Eliminate Atrial Fibrillation (ERADICA …
Managing peri-mitral flutter.
Lim MW, Kistler PM. Lim MW, et al. J Cardiovasc Electrophysiol. 2023 Oct;34(10):2145-2151. doi: 10.1111/jce.15808. Epub 2023 Jan 18. J Cardiovasc Electrophysiol. 2023. PMID: 36598419 Review.
The exponential rise in the incidence of peri-mitral flutter has paralleled the increasing use of more extensive atrial substrate ablation for atrial fibrillation (AF). Given the relative paucity of randomized evidence to support its role in AF management, mitral isthmus a …
The exponential rise in the incidence of peri-mitral flutter has paralleled the increasing use of more extensive atrial substrate ablation f …
Propafenone versus amiodarone for supraventricular arrhythmias in septic shock: a randomised controlled trial.
Balik M, Maly M, Brozek T, Rulisek J, Porizka M, Sachl R, Otahal M, Brestovansky P, Svobodova E, Flaksa M, Stach Z, Horejsek J, Volny L, Jurisinova I, Novotny A, Trachta P, Kunstyr J, Kopecky P, Tencer T, Pazout J, Belohlavek J, Duska F, Krajcova A, Waldauf P. Balik M, et al. Intensive Care Med. 2023 Nov;49(11):1283-1292. doi: 10.1007/s00134-023-07208-3. Epub 2023 Sep 12. Intensive Care Med. 2023. PMID: 37698594 Clinical Trial.
Both amiodarone and propafenone are available interventions, but their clinical effects have not yet been directly compared. METHODS: In this two-centre, prospective controlled parallel group double blind trial we recruited 209 septic shock patients with new-onset a …
Both amiodarone and propafenone are available interventions, but their clinical effects have not yet been directly compared. METHODS: …
Rationale and design of a large-scale, app-based study to identify cardiac arrhythmias using a smartwatch: The Apple Heart Study.
Turakhia MP, Desai M, Hedlin H, Rajmane A, Talati N, Ferris T, Desai S, Nag D, Patel M, Kowey P, Rumsfeld JS, Russo AM, Hills MT, Granger CB, Mahaffey KW, Perez MV. Turakhia MP, et al. Am Heart J. 2019 Jan;207:66-75. doi: 10.1016/j.ahj.2018.09.002. Epub 2018 Sep 8. Am Heart J. 2019. PMID: 30392584 Free PMC article. Clinical Trial.
Identification of pulse irregularity or variability from these data has the potential to identify atrial fibrillation or atrial flutter (AF, collectively). The rapidly expanding consumer base of these devices allows for detection of undiagnosed AF at scale. ...The A …
Identification of pulse irregularity or variability from these data has the potential to identify atrial fibrillation or atrial fl …
Diltiazem vs. Metoprolol in the Management of Atrial Fibrillation or Flutter with Rapid Ventricular Rate in the Emergency Department.
Fromm C, Suau SJ, Cohen V, Likourezos A, Jellinek-Cohen S, Rose J, Marshall J. Fromm C, et al. J Emerg Med. 2015 Aug;49(2):175-82. doi: 10.1016/j.jemermed.2015.01.014. Epub 2015 Apr 22. J Emerg Med. 2015. PMID: 25913166 Clinical Trial.
However, there is considerable regional variability in emergency physician practice patterns and debate among physicians as to which agent is more effective. To date, only one small prospective, randomized trial has compared the effectiveness of diltiazem and metopr …
However, there is considerable regional variability in emergency physician practice patterns and debate among physicians as to which agent i …
Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis.
Li HL, Lip GYH, Feng Q, Fei Y, Tse YK, Wu MZ, Ren QW, Tse HF, Cheung BY, Yiu KH. Li HL, et al. Cardiovasc Diabetol. 2021 May 7;20(1):100. doi: 10.1186/s12933-021-01293-8. Cardiovasc Diabetol. 2021. PMID: 33962654 Free PMC article.
Randomized controlled trials that randomized patients with DM, CKD, or HF to SGLT2i or placebo were included. The outcomes of interest include atrial fibrillation (AF), embolic stroke, atrial flutter (AFL), AF/AFL, ventricular tachycardia (VT), and car …
Randomized controlled trials that randomized patients with DM, CKD, or HF to SGLT2i or placebo were included. The outcomes of …
WITHDRAWN: Pharmacological cardioversion for atrial fibrillation and flutter.
Cordina J, Mead GE. Cordina J, et al. Cochrane Database Syst Rev. 2017 Nov 15;11(11):CD003713. doi: 10.1002/14651858.CD003713.pub3. Cochrane Database Syst Rev. 2017. PMID: 29140557 Free PMC article. Review.
We hand searched the following journals: Circulation (1997 to 2002), Heart (1997 to 2002), European Heart Journal (1997-2002), Journal of the American College of Cardiology (1997-2002) and selected abstracts published on the web site of the North American Society of Pacing and El …
We hand searched the following journals: Circulation (1997 to 2002), Heart (1997 to 2002), European Heart Journal (1997-2002), Journal of th …
Dronedarone.
Hoy SM, Keam SJ. Hoy SM, et al. Drugs. 2009 Aug 20;69(12):1647-63. doi: 10.2165/11200820-000000000-00000. Drugs. 2009. PMID: 19678715 Review.
Dronedarone exhibited rate- and rhythm-controlling properties in patients with atrial fibrilation (AF) or atrial flutter, significantly reducing the risk of a first recurrence of AF versus placebo following 12 months' therapy in the ADONIS and EURIDIS studies. ...Or …
Dronedarone exhibited rate- and rhythm-controlling properties in patients with atrial fibrilation (AF) or atrial flutter, sign …
WITHDRAWN: Electrical cardioversion for atrial fibrillation and flutter.
Mead GE, Elder A, Flapan AD, Cordina J. Mead GE, et al. Cochrane Database Syst Rev. 2017 Nov 15;11(11):CD002903. doi: 10.1002/14651858.CD002903.pub3. Cochrane Database Syst Rev. 2017. PMID: 29140555 Free PMC article. Review.
Personal contact was made with experts. SELECTION CRITERIA: Randomised controlled trial or controlled clinical trials of electrical cardioversion plus 'usual care' versus 'usual care' only, where 'usual care' included any combination of anticoagulants, antipl …
Personal contact was made with experts. SELECTION CRITERIA: Randomised controlled trial or controlled clinical trials o …
3,010 results